MoneyWorks4Me

SMS Pharmaceuticals informs about disclosure

15 Dec 2023 Evaluate
SMS Pharmaceuticals has informed that the exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on December 14, 2023 for Potluri Infra Projects LLP. 

The above information is a part of company’s filings submitted to BSE.
Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..